Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients. Nie X, Zou M, Song C, Zhang P, et al. BMC Cancer 2025;25:393.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nie X, Zou M, Song C, Zhang P, et al. Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients. BMC Cancer 2025;25:393.
PMID: 40038684